Witnessing the stock’s movement on the chart, on Wednesday, BeiGene Ltd ADR (NASDAQ: BGNE) had a quiet start as it plunged -4.87% to $205.99, before settling in for the price of $216.53 at the close. Taking a more long-term approach, BGNE posted a 52-week range of $126.97-$248.16.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 92.60%. Meanwhile, its Annual Earning per share during the time was 5.63%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 39.17%. This publicly-traded company’s shares outstanding now amounts to $97.34 million, simultaneously with a float of $96.46 million. The organization now has a market capitalization sitting at $20.05 billion. At the time of writing, stock’s 50-day Moving Average stood at $211.37, while the 200-day Moving Average is $171.33.
BeiGene Ltd ADR (BGNE) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. BeiGene Ltd ADR’s current insider ownership accounts for 0.90%, in contrast to 47.37% institutional ownership. According to the most recent insider trade that took place on Oct 08 ’24, this organization’s Chief Executive Officer sold 10,000 shares at the rate of 232.22, making the entire transaction reach 2,322,161 in total value, affecting insider ownership by 0. Preceding that transaction, on Oct 08 ’24, Company’s Chief Executive Officer sold 6,175 for 232.22, making the whole transaction’s value amount to 1,433,931. This particular insider is now the holder of 0 in total.
BeiGene Ltd ADR (BGNE) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.3 per share during the current fiscal year.
BeiGene Ltd ADR’s EPS increase for this current 12-month fiscal period is 39.17% and is forecasted to reach -0.60 in the upcoming year.
BeiGene Ltd ADR (NASDAQ: BGNE) Trading Performance Indicators
Let’s observe the current performance indicators for BeiGene Ltd ADR (BGNE). It’s Quick Ratio in the last reported quarter now stands at 1.75. The Stock has managed to achieve an average true range (ATR) of 7.57. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.48.
In the same vein, BGNE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.08, a figure that is expected to reach -1.04 in the next quarter, and analysts are predicting that it will be -0.60 at the market close of one year from today.
Technical Analysis of BeiGene Ltd ADR (BGNE)
Going through the that latest performance of [BeiGene Ltd ADR, BGNE]. Its last 5-days volume of 0.33 million indicated improvement to the volume of 0.26 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 30.15% While, its Average True Range was 7.35.
Raw Stochastic average of BeiGene Ltd ADR (BGNE) in the period of the previous 100 days is set at 60.53%, which indicates a major rise in contrast to 2.07% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 35.96% that was lower than 39.54% volatility it exhibited in the past 100-days period.
